Dna X (SONM) Current Assets (2018 - 2026)

Dna X has reported Current Assets for 9 years, with the latest figure at $3.3 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 87.74% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2026 stood at $3.3 million (down 87.74% YoY), and the FY2025 full-year result was $28.9 million, down 10.12% from the prior year.
• Current Assets for Q1 2026 stood at $3.3 million, down from $28.9 million in the prior quarter.
• The five-year high for Current Assets was $47.5 million in Q3 2023, with the low at $3.3 million in Q1 2026.
• Historically, Current Assets has averaged $33.5 million across 5 years, with a median of $32.6 million in 2024.
• Annual changes were most pronounced in 2023 — Current Assets jumped 39.42% — and 2026, when it plunged 87.74%.
• Dna X's Current Assets stood at $43.6 million in 2022, then grew by 0.36% to $43.8 million in 2023, then retreated by 26.54% to $32.2 million in 2024, then retreated by 10.12% to $28.9 million in 2025, then tumbled by 88.57% to $3.3 million in 2026.
• The last three Current Assets figures came in at $3.3 million (Q1 2026), $28.9 million (Q4 2025), and $30.3 million (Q3 2025), per Business Quant data.